Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

New colorectal cancer diagnosis through biomarkers

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOES20210204001
Publicado:
12/02/2021
Caducidad:
13/02/2022
Resumen:
A Spanish (Basque) scientific foundation specialized in R-Y-D and innovation management for the healthcare system seeks a company to license a non-invasive method for the screening, diagnosis or monitoring of colorectal cancer and/or advanced adenoma.

Details

Tittle:
New colorectal cancer diagnosis through biomarkers
Summary:
A Spanish (Basque) scientific foundation specialized in R-Y-D and innovation management for the healthcare system seeks a company to license a non-invasive method for the screening, diagnosis or monitoring of colorectal cancer and/or advanced adenoma.
Description:
Colorectal cancer (CRC) is the second leading cause of cancer death in developed countries. Certain studies affirm that detecting precancerous polyps can reduce both colorectal cancer incidence and mortality by 30% and 50% respectively. A colonoscopy is currently considered to be the most accurate test for early detection of CRC, but it has the limitation of causing a low level of adherence in patients due to the discomfort of the test and the preparations required.
This invention provides a new screening and/or diagnostic method, both for the precancerous stage (advanced adenoma) and for CRC, based on identifying the level of certain metabolic markers present in a faeces sample collected from the patient.

Advantages and Innovations:
Nowadays, the main diagnosis method for CRC is colonoscopy. This method does not have a high adherence in patients and so, this new diagnostic method through biomarkers is easier to be accepted by patients as it is a non-invasive method. Thus, no break in the skin is created and there is no contact with the mucosa, or skin break, or internal body cavity beyond a natural or artificial body orifice.
Moreover, this method allows an early diagnosis of the disease in precancerous stages which is not possible at this moment.
In summary, a new method of screening, diagnosis and/or monitoring of advanced adenoma and/or colorectal cancer in patients. It will be non-invasive and able to diagnose diseases in precancerous stages.
Stage of Development:
Under development/lab tested
IPs:
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
European Patent Application
USA -Y- Canada

Partner sought

Type and Role of Partner Sought:
The Spanish (Basque) organization is offering a license agreement to experienced companies in preclinical and clinical development of medical devices and diagnostic kits interested in acquiring this technology. Moreover, this license offer seeks both options: On the one side, companies willing to commercialise, but also companies interested in enhancing the invention.
It would be preferable for the partner to be a healthcare facility so that the validation of the method can be carried out. Nevertheless, this is not compulsory.

Client

Type and Size of Client:
R&D Institution
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English
Spanish

Keywords

Technology Keywords:
06001005 Diagnósticos, diagnosis
06001002 Investigaciones clínicas, ensayos
06001012 Investigaciones médicas
06001013 Tecnología médica / ingeniería biomédica